HansBiomed Corporation - Asset Resilience Ratio

Latest as of March 2025: 9.13%

HansBiomed Corporation (042520) has an Asset Resilience Ratio of 9.13% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HansBiomed Corporation current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩11.75 Billion

≈ $7.96 Million USD Cash + Short-term Investments

Total Assets

₩128.60 Billion

≈ $87.15 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2023)

This chart shows how HansBiomed Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 042520 asset base.

Liquid Assets Composition Over Time

This chart breaks down HansBiomed Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 042520 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩11.75 Billion	9.13%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩11.75 Billion	9.13%

Asset Resilience Insights

Limited Liquidity: HansBiomed Corporation maintains only 9.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

HansBiomed Corporation Industry Peers by Asset Resilience Ratio

Compare HansBiomed Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medtronic plc SA:MDTC34	Medical Devices	7.82%
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Biosynex PA:ALBIO	Medical Devices	3.35%

Annual Asset Resilience Ratio for HansBiomed Corporation (2012–2023)

The table below shows the annual Asset Resilience Ratio data for HansBiomed Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-09-30	0.75%	₩916.26 Million ≈ $620.93K	₩122.37 Billion ≈ $82.93 Million	-10.63pp
2022-09-30	11.38%	₩14.98 Billion ≈ $10.15 Million	₩131.69 Billion ≈ $89.24 Million	-4.28pp
2021-09-30	15.66%	₩20.27 Billion ≈ $13.74 Million	₩129.44 Billion ≈ $87.72 Million	-2.22pp
2020-09-30	17.88%	₩23.57 Billion ≈ $15.97 Million	₩131.81 Billion ≈ $89.32 Million	+10.12pp
2019-09-30	7.76%	₩10.40 Billion ≈ $7.05 Million	₩134.09 Billion ≈ $90.87 Million	-1.68pp
2018-09-30	9.44%	₩8.66 Billion ≈ $5.87 Million	₩91.80 Billion ≈ $62.21 Million	+3.53pp
2017-09-30	5.90%	₩4.73 Billion ≈ $3.21 Million	₩80.19 Billion ≈ $54.34 Million	+2.61pp
2016-09-30	3.29%	₩2.13 Billion ≈ $1.44 Million	₩64.72 Billion ≈ $43.86 Million	+3.27pp
2015-09-30	0.02%	₩9.04 Million ≈ $6.13K	₩52.11 Billion ≈ $35.32 Million	-0.13pp
2014-09-30	0.15%	₩67.25 Million ≈ $45.58K	₩44.34 Billion ≈ $30.05 Million	-0.09pp
2013-09-30	0.25%	₩81.89 Million ≈ $55.50K	₩33.36 Billion ≈ $22.61 Million	-15.68pp
2012-09-30	15.92%	₩4.31 Billion ≈ $2.92 Million	₩27.05 Billion ≈ $18.33 Million	--

pp = percentage points

About HansBiomed Corporation

KQ:042520 Korea Medical Devices

Market Cap

$159.83 Million

₩235.84 Billion KRW

Market Cap Rank

#17488 Global

#710 in Korea

Share Price

₩18160.00

Change (1 day)

-2.47%

52-Week Range

₩13160.00 - ₩55700.00

All Time High

₩55700.00